Paclitaxel, ifosfamide and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group

1 Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy BJU International, May 2, 2013

2 The survival benefit of lymph node dissection at the time of removal of kidney, prostate and urothelial carcinomas: what is the evidence? World Journal of Urology, May 6, 2013    Review Article

3 Assessing the invasive potential of bladder cancer: development and validation of a new preclinical assay The Journal of Urology, May 6, 2013

4 Inhibition of presenilins attenuates proliferation and invasion in bladder cancer cells through multiple pathways Urologic Oncology: Seminars and Original Investigations, May 14, 2013

5 Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma The Journal of Urology, May 13, 2013

6 Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer British Journal of Cancer, May 10, 2013

7 Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience The Journal of Urology, May 15, 2013

8 Zoledronic acid in genitourinary cancer Clinical and Translational Oncology, April 30, 2013

9 Expression of Bone Morphogenetic Protein-10 (BMP10) in Human Urothelial Cancer of the Bladder and its Effects on the Aggressiveness of Bladder Cancer Cells In Vitro Anticancer Research, May 7, 2013

10 Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C International Urogynecology Journal, May 15, 2013